This article is more than 5 years old. Information may no longer be current.

Stem cell therapy for retinal diseases shows early potential

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

GUILDFORD, England — A stem cell therapy program for diseases of the retina has shown initial survival efficacy data, according to a press release.

ReNeuron Group said its ReN003 stem cell therapy program “showed expansion of human retinal progenitor cells with markers of photoreceptors over multiple population doublings,” the release said.

“These progenitors showed an ability to engraft and protect the photoreceptor layer of the retina from degeneration in a retinal dystrophic model,” ReNeuron said.

In other company news, ReNeuron announced it will work with researchers at Schepens Eye Research Institute “to establish the key conditions for growing retinal stem cell lines that can be developed into a scalable, efficacious and safe therapy.”